Related Experiment Video
Updated: Jun 6, 2026

Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Haplo-insufficiency: a driving force in cancer
Alice H Berger1, Pier Paolo Pandolfi
1Cancer Genetics Program, Beth Israel Deaconess Cancer Center, Department of Medicine, Harvard Medical School, Boston, MA, USA.
Many tumor suppressor genes (TSGs) are haplo-insufficient, meaning one functional copy is not enough to prevent cancer. Identifying these genes, like DOK2, requires mouse models and understanding gene interactions for better cancer diagnostics and treatment.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Tumor suppressor genes (TSGs) were initially thought to function recessively.
- However, many TSGs, such as p53 and PTEN, display haplo-insufficiency due to dose-dependent function.
- Haplo-insufficiency means that having only one functional copy of the gene is insufficient to suppress tumor formation.
Purpose of the Study:
- To highlight the significance of haplo-insufficiency in tumor suppressor genes.
- To emphasize the role of mouse models in identifying haplo-insufficient TSGs.
- To discuss the clinical implications of understanding TSG haplo-insufficiency for diagnostics and therapeutics.
Main Methods:
- Review of existing literature on tumor suppressor gene function.
- Case study examples including p53, PTEN, and DOK2.
- Discussion of genetic syndromes like 5q deletion syndrome as models of compound haplo-insufficiency.
Main Results:
- Numerous TSGs exhibit haplo-insufficiency, challenging the recessive model.
- Mouse models are crucial for identifying haplo-insufficient TSGs, exemplified by DOK2 in lung cancer.
- Conditional and compound haplo-insufficiency, as seen in 5q(-) syndrome, underscores gene interaction importance.
Conclusions:
- Integrating haplo-insufficiency concepts is vital for timely TSG identification in basic research.
- Clinical molecular pathology needs quantitative methods to assess haplo-insufficient genes in tumors.
- Accurate assessment of haplo-insufficient genes can improve prognostic predictions and guide therapy selection.
Related Concept Videos
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

